Quantification of MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool by Absolute Digital(d)PCR*

Journal Title: Surgery & Case Studies: Open Access Journal - Year 2019, Vol 1, Issue 5

Abstract

There is currently no validated micro(mi)RNA diagnostic stool test to screen for colon cancer (CC) on the market because of the complexity of fecal density, vulnerability of stool to daily changes, and the presence of three sources of miRNAs in stool (cell-free from fecal homogenates, exsosomal miRNAs from fecal exosomes, and fecal colonocytes). By employing earlier on a microarray miRNA experiment, using Affymetrix GeneChip miRNA 2.0 Arrays, on immunocaptured and enriched stool colonocytes of 15 subjects [three healthy controls and twelve colon cancer patients [three TNM stage 0-1 (e.g., polyps  1 cm, villous or tubvillous, or with high grade dysplasia), three stage 2, three stage 3, and three stage 4] in triplicates, this allowed for selection of a smaller panel of 14 preferentially expressed mature miRNAs associated with colon cancer (12 Up-Regulated, miR-19a, miR-20a, miR-21, miR-31, miR-34a, miR-96, miR-106a, miR-133a, miR-135b, miR-206, miR-224 and miR-302; and 2 Down-Regulated, miR-143 and miR-145). Then carrying out an absolute quantitative digital PCR on these 15 stool samples from TNM stages 0-4 on total small RNA extracted by immunocapture, followed by RT that employed a Custom TaqMan® miRNA Reverse Transcription (RT) Kit and TaqMan RT Primer Pool, and absolute quantification of miRNAs, in copies/μl, measured using a chip-based Absolute QuantStudio 3D Digital PCR analysis, allowed for validating the microarray results. To ensure that human and not bacterial small total RNA was chosen, coextraction protocols with E. coli K1 strain RS18 was carried out, followed by comparing Agilent electrophoretic patterns with human and bacterial electrophoretic patterns, and also random samples were sequenced using mRNA/miRNA sequencing, to ensure that human and not bacterial mRNA was chosen.

Authors and Affiliations

Farid E Ahmed, Mostafa M Gouda, Nancy C Ahmed

Keywords

Related Articles

Intestinal Obstruction by Blind Vove Iess Riobamba Hospital 2014

Introduction: Cecal volvulus is the second most common volvulus among colonic volvulus, usually presenting as bowel obstruction. Case Presentation: A 65 year old female presented with abdominal pain, nausea, vomiting, ab...

Segmental Neurofibromatosis: Two Moroccan Cases

Segmental neurofibromatosis (SN) or type V Neurofibromatosis is a genodermatos most often characterized by the presence of neurofibromas, more rarely café au lait spots, and sometimes lentigines limited to a limited body...

Quantification of MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool by Absolute Digital(d)PCR*

There is currently no validated micro(mi)RNA diagnostic stool test to screen for colon cancer (CC) on the market because of the complexity of fecal density, vulnerability of stool to daily changes, and the presence of th...

Under-Five Child Health Service Quality and its Determinants in Goncha Siso Enessie District, Northwest Ethiopia, 2016

Background: Quality of health service is measured based on structure, process and outcome elements and has multidimensional concept that has been defined in various ways. It is an important aspect of health service deliv...

Surgical Management of Multiple Nevus Lipomatosis Superficialis: A Case Report

Nevus lipomatosis superficialis is a rare skin lesion characterized by the ectopic dermal deposition of adipose tissue. While benign, it typically presents in the second to third decade of life as regional discomfort. We...

Download PDF file
  • EP ID EP639333
  • DOI 10.32474/SCSOAJ.2019.01.000125
  • Views 51
  • Downloads 0

How To Cite

Farid E Ahmed, Mostafa M Gouda, Nancy C Ahmed (2019). Quantification of MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool by Absolute Digital(d)PCR*. Surgery & Case Studies: Open Access Journal, 1(5), 110-118. https://europub.co.uk/articles/-A-639333